RxDoctor Payments Data

Kristy Mumby

Primary Care · Kalamazoo, MINPI 1609485481

Payments from drug & device makers

$942in general payments, 2019–2025

Across 47 payments — averaging $20.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$131
  • Sumitomo Pharma America, Inc.$108
  • Medtronic$92
  • Astellas Pharma US Inc$77
  • Vertex$58
  • Johnson & Johnson$52
  • plus $424 from 17 others

What the payments were for

  • Food & beverage$942100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$942 in reported general payments places this provider in the 65th percentile of 292 primary care providers in Michigan.

See all primary care providers in Michigan

Medicare billing

Part B allowed, 2024
$7,771
Medicare patients
110
Services billed
141

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron92$60,740
GemtesaVibegron11$8,847
Tamsulosin Hcl242$5,500
Trospium Chloride ErTrospium Chloride15$2,742
Finasteride160$2,285
Tolterodine Tartrate ErTolterodine Tartrate14$2,011
Solifenacin Succinate66$1,670
Estradiol21$1,497
Methenamine Hippurate21$1,099
Oxybutynin Chloride ErOxybutynin Chloride25$592
Trospium Chloride19$524
Cephalexin36$214
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav12$55
Doxycycline Hyclate13$35
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim15$23

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Astellas Pharma US IncMyrbetriq$77$60,74092 claims
Sumitomo Pharma America, Inc.Gemtesa$108$8,84711 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 292 primary care providers in Michigan.

Other primary care in Kalamazoo

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →